FBLG CIK: 1958777

FibroBiologics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25

Assets

(positive)
Change from FY22 to FY25
millions USD
FY22:
2.63
FY23:
9.22
FY24:
14.2
FY25:
6.35
(positive)
Change from FY22 to FY25
millions USD
FY22:
2.20
FY23:
2.61
FY24:
2.22
FY25:
3.27
Total assets
Change from FY22 to FY25
millions USD
FY22:
4.82
FY23:
11.8
FY24:
16.4
FY25:
9.62

Liabilities & Equity

(negative)
Change from FY22 to FY25
millions USD
FY22:
7.07
FY23:
9.18
FY24:
12.7
FY25:
1.76
(negative)
Change from FY22 to FY25
millions USD
FY22:
1.75
FY23:
1.39
FY24:
0.98
FY25:
1.70
(positive)
Change from FY22 to FY25
millions USD
FY22:
−4.00
FY23:
1.25
FY24:
2.74
FY25:
6.16
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY22:
4.82
FY23:
11.8
FY24:
16.4
FY25:
9.62

All amounts in millions USD Data source:SEC EDGAR